Here are the latest quarterly results of ZYDUS LIFESCIENCES. For more details, see the ZYDUS LIFESCIENCES financial fact sheet and ZYDUS LIFESCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 42,571 | 50,106 | 51,396 | 43,688 | 45,052 | 55,338 | 62,075 | 52,370 | |
Other income | Rs m | 1,437 | 378 | 360 | 1,362 | 583 | 1,617 | 632 | 1,136 | |
Turnover | Rs m | 44,008 | 50,484 | 51,756 | 45,050 | 45,635 | 56,955 | 62,707 | 53,506 | |
Expenses | Rs m | 34,063 | 37,550 | 36,343 | 33,049 | 34,234 | 39,086 | 41,235 | 38,210 | |
Gross profit | Rs m | 8,508 | 6,543 | 14,911 | 10,639 | 10,818 | 16,252 | 20,840 | 14,160 | |
Depreciation | Rs m | 1,816 | 1,786 | 1,798 | 1,842 | 1,948 | 2,053 | 2,153 | 2,336 | |
Interest | Rs m | 328 | 277 | 181 | 87 | 198 | 346 | 322 | 251 | |
Profit before tax | Rs m | 7,801 | 4,858 | 13,292 | 10,072 | 9,255 | 15,470 | 18,997 | 12,709 | |
Tax | Rs m | 1,952 | 1,372 | 2,161 | 2,264 | 2,138 | 3,212 | 4,361 | 3,731 | |
Profit after tax | Rs m | 5,849 | 3,486 | 11,131 | 7,808 | 7,117 | 12,258 | 14,636 | 8,978 | |
Gross profit margin | % | 20.0 | 13.1 | 29.0 | 24.4 | 24.0 | 29.4 | 33.6 | 27.0 | |
Effective tax rate | % | 25.0 | 28.2 | 16.3 | 22.5 | 23.1 | 20.8 | 23.0 | 29.4 | |
Net profit margin | % | 13.7 | 7.0 | 21.7 | 17.9 | 15.8 | 22.2 | 23.6 | 17.1 | |
Diluted EPS | Rs | 5.8 | 3.5 | 11.1 | 7.8 | 7.1 | 12.2 | 14.5 | 8.9 | |
Diluted EPS (TTM) | Rs | 21.0 | 19.9 | 25.4 | 28.1 | 29.4 | 38.1 | 41.6 | 42.7 | |
Subscriber Feature |
Asian markets traded higher on Friday, following the overnight rally on Wall Street, and the release of economic data in the region.